Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients-Reference-Cited by-同舟云学术

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

Published:2006-01-24 Issue:3 Volume:51 Page:249-253
ISSN:1434-5161
Container-title:Journal of Human Genetics
language:en
Short-container-title:J Hum Genet

Author:

Mushiroda Taisei,Ohnishi Yozo,Saito Susumu,Takahashi Atsushi,Kikuchi Yuka,Saito Shigeru,Shimomura Hideki,Wanibuchi Yasuhiko,Suzuki Takao,Kamatani Naoyuki,Nakamura Yusuke

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/jhg200637.pdf

Reference20 articles.

1. Breckenridge A, Orme M, Wesseling H, Lewis RJ, Gibbons R (1974) Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther 15:424–430

2. D’Andrea G, D’Ambrosio RL, Di Perna P, Chetta M, Santacroce R, Brancaccio V, Grandone E, Margaglione M (2005) A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 105:645–649

3. Harrington DJ, Underwood S, Morse C, Shearer MJ, Tuddenham EG, Mumford AD (2005) Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1. Thromb Haemost 93:23–26

4. Iida A, Sekine A, Saito S, Kitamura Y, Kitamoto T, Osawa S, Mishima C, Nakamura Y (2001) Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes. J Hum Genet 46:225–240

5. Kimura M, Ieiri I, Mamiya K, Urae A, Higuchi S (1998) Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther Drug Monit 20:243–247

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report;Journal of Pharmaceutical Health Care and Sciences;2023-05-01

2. Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant;Indian Journal of Pharmacology;2023-01

3. VKORC1 gene polymorphism (-1639G>A) in warfarin therapy patients of Pakistani population;Journal of the Pakistan Medical Association;2022-02-03

4. Multiplex SNP Genotyping Using SWITCH: Sequence‐Specific Nanoparticle with Interpretative Toehold‐Mediated Sequence Decoding in Hydrogel;Small;2021-12-19

5. The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies;Pharmaceutical Biology;2021-01-01